Related Experiment Video
Updated: Jul 7, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Postoperative chemotherapy in non-small cell lung cancer]
B Milleron1, V Gounant, Eacute Giroux-Leprieur
1UF d'Oncologie Thoracique, Hôpital Tenon, Cancer Est, Paris, France. bernard.milleron@tnn.ap-hp.fr
Abstract:
Since 2000, seven prospective randomized studies were published or reported comparing surgery and surgery with post-operative chemotherapy for the treatment of non-small cell lung cancer (NSCLC). Four trials (IALT, UFT, JBR10 and ANITA) are positive and have proved the benefit obtained with post-operative chemotherapy for the stages II and IIIA. For the stage IB, this survival increase is also probable, especially for the tumors higher than 4 cm. Several biologic markers are under investigation as predictors of the benefit of the chemotherapy.
